These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9652875)

  • 1. Long-term mortality follow-up of hospital survivors of a myocardial infarction randomized to nifedipine in the SPRINT study. Secondary Prevention Reinfarction Israeli Nifedipine Trial.
    Reicher-Reiss H; Behar S; Boyko V; Mandelzweig L; Kaplinsky E; Goldbourt U
    Cardiovasc Drugs Ther; 1998 May; 12(2):171-6. PubMed ID: 9652875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nifedipine and cancer mortality: ten-year follow-up of 2607 patients after acute myocardial infarction.
    Jonas M; Goldbourt U; Boyko V; Mandelzweig L; Behar S; Reicher-Reiss H
    Cardiovasc Drugs Ther; 1998 May; 12(2):177-81. PubMed ID: 9652876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary prevention reinfarction Israeli nifedipine trial (SPRINT). A randomized intervention trial of nifedipine in patients with acute myocardial infarction. The Israeli Sprint Study Group.
    Eur Heart J; 1988 Apr; 9(4):354-64. PubMed ID: 2898363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study.
    Goldbourt U; Behar S; Reicher-Reiss H; Zion M; Mandelzweig L; Kaplinsky E
    Arch Intern Med; 1993 Feb; 153(3):345-53. PubMed ID: 8285927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors and long-term prognostic significance of recurrent infarction in the year after a first myocardial infarction. SPRINT Study Group.
    Kornowski R; Goldbourt U; Zion M; Mandelzweig L; Kaplinsky E; Levo Y; Behar S
    Am J Cardiol; 1993 Oct; 72(12):883-8. PubMed ID: 8213543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myocardial infarction beyond the 48 first hours: treatment with calcium channel antagonists].
    Delahaye F; de Gevigney G; Ovize M; Landrivon G; Rabilloud M; André-Fouët X; Delaye J
    Arch Mal Coeur Vaiss; 1992 Nov; 85(11 Suppl):1717-24. PubMed ID: 1304145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digoxin and mortality in survivors of acute myocardial infarction: observations in patients at low and intermediate risk. The SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial.
    Leor J; Goldbourt U; Behar S; Boyko V; Reicher-Reiss H; Kaplinsky E; Rabinowitz B
    Cardiovasc Drugs Ther; 1995 Aug; 9(4):609-17. PubMed ID: 8547212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nifedipine in secondary prevention after myocardial infarction. SPRINT Study Group].
    Harefuah; 1989 Jan; 116(1):1-6. PubMed ID: 2651233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial infarction. Secondary prevention with nifedipine.
    Rafflenbeul W; Ebner F
    Drugs; 1991; 42 Suppl 2():38-42. PubMed ID: 1718700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty-five-year mortality rate decrease in patients in Israel with a first episode of acute myocardial infarction. Secondary Prevention Reinfarction Israeli Nifedipine Trial Study Group. Israeli Thrombolytic Survey Group.
    Behar S; Goldbourt U; Barbash G; Modan B
    Am Heart J; 1995 Sep; 130(3 Pt 1):453-8. PubMed ID: 7661060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium antagonists in secondary prevention after acute myocardial infarction: the Secondary Prevention Reinfarction Nifedipine Trial (SPRINT).
    Neufeld HN
    Eur Heart J; 1986 Jul; 7 Suppl B():51-2. PubMed ID: 3530769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroke risk after anterior wall acute myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial.
    Tanne D; Reicher-Reiss H; Boyko V; Behar S
    Am J Cardiol; 1995 Oct; 76(11):825-6. PubMed ID: 7572664
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term prognosis of women after myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial.
    Benderly M; Behar S; Reicher-Reiss H; Boyko V; Goldbourt U
    Am J Epidemiol; 1997 Jul; 146(2):153-60. PubMed ID: 9230777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethnic differences in mortality of male and female patients surviving acute myocardial infarction: long-term follow-up of 5,700 patients. The Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) Study Group.
    Harpaz D
    Eur J Epidemiol; 1997 Oct; 13(7):745-54. PubMed ID: 9384262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate and long-term prognostic significance of a first anterior versus first inferior wall Q-wave acute myocardial infarction. Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) Study Group.
    Behar S; Rabinowitz B; Zion M; Reicher-Reiss H; Kaplinsky E; Abinader E; Agmon J; Friedman Y; Kishon Y; Palant A
    Am J Cardiol; 1993 Dec; 72(18):1366-70. PubMed ID: 8256728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of short- and long-term prognosis in patients with anterior wall versus inferior or lateral wall non-Q-wave acute myocardial infarction. Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) Study Group.
    Haim M; Hod H; Reisin L; Kornowski R; Reicher-Reiss H; Goldbourt U; Boyko V; Behar S
    Am J Cardiol; 1997 Mar; 79(6):717-21. PubMed ID: 9070547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Calcium antagonists in the secondary prevention of myocardial infarction].
    Lièvre M; Nony P
    Therapie; 1993; 48 Spec No():677-83. PubMed ID: 8091354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of infarction location in patients with recurrent myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israel Nifedipine Trial.
    Kornowski R; Goldbourt U; Reicher-Reiss H; Reisin L; Haim M; Moshkovitz Y; Caspi A; Behar S
    Cardiology; 1997; 88(5):441-5. PubMed ID: 9286506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved survival of hospitalized patients with acute myocardial infarction from 1981-1983 to 1992 in Israel. The SPRINT Study Group and The Israeli Thrombolytic Survey Group. Secondary Prevention Israeli Nifedipine Trial.
    Behar S; Barbash GI; Copel L; Gottlieb S; Goldbourt U
    Coron Artery Dis; 1994 Dec; 5(12):1001-7. PubMed ID: 7728292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of patients with a first non-Q-wave myocardial infarction before and in the reperfusion era. SPRINT and the Israeli Thrombolytic Survey Groups. Secondary Prevention Reinfarction Israeli Nifedipine Trial.
    Haim M; Gottlieb S; Boyko V; Reicher-Reiss H; Hod H; Kaplinsky E; Mandelzweig L; Goldbourt U; Behar S
    Am Heart J; 1998 Aug; 136(2):245-51. PubMed ID: 9704685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.